Fever of Unknown Origin in Pediatric Age

Introduction & Background

Historical Perspective

Evolution of FUO definition since Petersdorf and Beeson's criteria (1961)
Changes in epidemiology with advent of modern diagnostics
Impact of emerging pathogens and resistant organisms
Role of modern imaging in changing diagnostic approach

Pathophysiological Considerations

Cytokine-mediated fever mechanisms:
- IL-1β, TNF-α, and IL-6 pathways
- Hypothalamic temperature reset
- Role of prostaglandin E2
Host immune response patterns:
- Innate immune activation
- Adaptive immune responses
- Inflammatory mediators

Clinical Significance

Impact on healthcare utilization:
- Length of hospital stay
- Resource utilization
- Economic burden
Quality of life considerations:
- Physical limitations
- School attendance
- Family dynamics

Definition & Classification

Classical Definition Criteria

Temperature Requirements:
- Core temperature ≥38.3°C (101°F)
- Documentation methods:
  - Oral temperature measurement
  - Rectal temperature (gold standard)
  - Axillary temperature (less reliable)
Duration Requirements:
- ≥8 days for classical definition
- Modified criteria for specific age groups
- Continuous vs. recurrent fever patterns
Diagnostic Evaluation:
- Initial outpatient workup
- Three outpatient visits or
- Three days of inpatient investigation

Age-Specific Modifications

Age Group	Temperature Criteria	Duration	Special Considerations
Neonates (0-28 days)	≥38.0°C	Any duration	Requires immediate evaluation
Infants (1-12 months)	≥38.0°C	≥7 days	Lower threshold for investigation
Children (>12 months)	≥38.3°C	≥8 days	Classical criteria apply

Detailed Etiology

1. Infectious Causes (40-50%)

A. Bacterial Infections

Occult Bacteremia:
- Streptococcus pneumoniae
- Neisseria meningitidis
- Salmonella species
Deep-seated Infections:
- Osteomyelitis:
  - Staphylococcus aureus (most common)
  - Group A Streptococcus
  - Kingella kingae in young children
- Endocarditis:
  - Viridans streptococci
  - Staphylococcus aureus
  - HACEK organisms
- Intra-abdominal Abscesses:
  - Liver abscess
  - Psoas abscess
  - Post-operative collections

B. Viral Infections

Epstein-Barr Virus:
- Clinical patterns
- Age-specific presentations
- Chronic active infection
Cytomegalovirus:
- Primary infection
- Reactivation disease
- Congenital implications
HIV:
- Acute retroviral syndrome
- Opportunistic infections
- AIDS-defining illnesses

C. Mycobacterial Infections

Tuberculosis:
- Pulmonary manifestations
- Extrapulmonary disease:
  - Miliary TB
  - TB lymphadenitis
  - CNS involvement
Non-tuberculous Mycobacteria:
- MAC complex
- M. kansasii
- Rapid growers

2. Rheumatologic/Inflammatory Causes (20-25%)

Juvenile Idiopathic Arthritis:
- Systemic onset (Still's disease):
  - Quotidian fever pattern
  - Evanescent rash
  - Arthritis features
- Other subtypes
Systemic Vasculitides:
- Kawasaki Disease:
  - Complete vs. incomplete
  - Age-specific features
  - Cardiac complications
- Polyarteritis Nodosa:
  - Classic presentation
  - Cutaneous variant

3. Neoplastic Conditions (10-15%)

Hematologic Malignancies:
- Leukemia:
  - ALL patterns
  - AML presentations
  - Associated features
- Lymphoma:
  - Hodgkin's disease
  - Non-Hodgkin lymphoma
  - B symptoms
Solid Tumors:
- Neuroblastoma
- Wilms tumor
- Hepatoblastoma

Clinical Assessment

History Taking

Fever Characteristics:
- Pattern analysis:
  - Continuous vs intermittent
  - Quotidian patterns
  - Pel-Ebstein fever
- Associated symptoms timing
- Response to antipyretics
Exposure History:
- Travel history:
  - International travel
  - Endemic area exposure
  - Timing relative to symptoms
- Animal contacts:
  - Domestic pets
  - Farm animals
  - Wild animal exposure
- Environmental factors:
  - Living conditions
  - School/daycare exposure
  - Recreational activities

Physical Examination Techniques

General Examination:
- Growth parameters:
  - Height/weight trends
  - Growth velocity
  - BMI assessment
- Vital signs patterns:
  - Temperature variations
  - Heart rate patterns
  - Respiratory rate changes
  - Blood pressure tracking
Systematic Examination:
- Skin and mucous membranes:
  - Rash characteristics
  - Petechiae/purpura
  - Oral ulcers
- Lymph node examination:
  - Size and consistency
  - Distribution patterns
  - Associated features

Diagnostic Algorithms

Stage 1: Initial Evaluation

Laboratory Studies:
- Complete Blood Count with Differential:
  - Neutrophilia: bacterial infection
  - Lymphocytosis: viral infection
  - Pancytopenia: malignancy
  - Eosinophilia: parasitic/allergic
- Inflammatory Markers:
  - ESR patterns and interpretation
  - CRP trending
  - Procalcitonin levels
  - Ferritin (for HLH)
- Basic Metabolic Panel:
  - Electrolyte disturbances
  - Renal function
  - Acid-base status
- Liver Function Tests:
  - Transaminitis patterns
  - Cholestatic markers
  - Synthetic function
Microbiological Studies:
- Blood Cultures:
  - Aerobic/anaerobic sets
  - Number of samples needed
  - Timing relative to fever
- Urine Studies:
  - Urinalysis interpretation
  - Culture techniques
  - Catheterization vs. clean catch

Stage 2: Targeted Investigations

Serological Testing:
- Viral Studies:
  - EBV panel interpretation
  - CMV PCR/antigenemia
  - HIV testing protocols
  - Viral hepatitis markers
- Autoimmune Markers:
  - ANA and patterns
  - RF/Anti-CCP
  - Complement levels
  - ANCA testing
Imaging Studies:
- Chest Radiography:
  - Standard views
  - Pattern recognition
  - Follow-up intervals
- Advanced Imaging:
  - CT protocols:
    - Contrast considerations
    - Radiation exposure
    - Timing of study
  - MRI indications:
    - Sequence selection
    - Contrast protocols
    - Sedation needs
  - Nuclear Medicine:
    - PET-CT indications
    - Gallium scans
    - Tagged WBC studies

Stage 3: Invasive Diagnostics

Tissue Sampling:
- Bone Marrow Studies:
  - Aspiration technique
  - Biopsy indications
  - Culture protocols
  - Cytogenetic studies
- Lymph Node Biopsy:
  - Fine needle aspiration
  - Excisional biopsy
  - Processing protocols

FUO algorithm in children. (source)

Second-Line Laboratory Tests. (source)

Comprehensive Differential Diagnosis

Age-Specific Considerations

Neonates (0-28 days):
- Infectious:
  - Bacterial sepsis
  - Congenital infections
  - Healthcare-associated infections
- Non-infectious:
  - Drug fever
  - Metabolic disorders
  - Congenital malformations
Infants (1-12 months):
- Primary Immunodeficiencies:
  - SCID presentations
  - Chronic granulomatous disease
  - Hyper-IgE syndrome
- Inflammatory Conditions:
  - Kawasaki disease
  - Inflammatory bowel disease
  - Auto-inflammatory syndromes
Children (>12 months):
- Rheumatologic:
  - JIA subtypes
  - SLE presentations
  - Vasculitis patterns
- Oncologic:
  - Leukemia variants
  - Lymphoma types
  - Solid tumors

Pattern-Based Analysis

Periodic Fevers:
- PFAPA syndrome:
  - Diagnostic criteria
  - Clinical course
  - Treatment response
- Hereditary Fever Syndromes:
  - FMF characteristics
  - TRAPS features
  - Hyper-IgD syndrome

Comprehensive Management

General Principles

Supportive Care:
- Temperature Management:
  - Antipyretic protocols
  - Physical cooling methods
  - Monitoring parameters
- Fluid Management:
  - Hydration assessment
  - Electrolyte monitoring
  - IV fluid protocols
- Nutritional Support:
  - Caloric requirements
  - Feeding strategies
  - Supplementation needs

Disease-Specific Therapy

Infectious Causes:
- Empiric Antimicrobial Therapy:
  - Agent selection
  - Duration guidelines
  - Monitoring parameters
- Targeted Therapy:
  - Culture-directed antibiotics
  - Antiviral protocols
  - Antifungal considerations
Rheumatologic/Inflammatory:
- NSAIDs:
  - Agent selection
  - Dosing strategies
  - Monitoring needs
- Corticosteroids:
  - Indications
  - Dosing protocols
  - Tapering schedules
- Disease-Modifying Agents:
  - Traditional DMARDs
  - Biologic agents
  - Combination strategies
Neoplastic Conditions:
- Referral Guidelines:
  - Timing of referral
  - Specialist selection
  - Required information
- Initial Management:
  - Supportive measures
  - Pain control
  - Psychosocial support

Special Considerations

Immunocompromised Host

Modified Approach:
- Risk Stratification:
  - Neutropenia severity
  - Duration of immunosuppression
  - Recent interventions
- Diagnostic Modifications:
  - Expanded cultures
  - Fungal surveillance
  - Viral monitoring

Critical Care Considerations

Monitoring Parameters:
- Hemodynamic monitoring
- Respiratory assessment
- End-organ perfusion
Intervention Criteria:
- ICU transfer indicators
- Ventilatory support
- Circulatory support

Prognosis & Follow-up

Outcome Measures

Disease-Specific Outcomes:
- Infectious causes:
  - Resolution rates
  - Recurrence risk
  - Complication profiles
- Rheumatologic conditions:
  - Remission criteria
  - Disease activity scores
  - Functional outcomes
- Malignant conditions:
  - Survival rates
  - Response criteria
  - Long-term sequelae

Follow-up Protocols

Monitoring Schedule:
- Frequency of visits
- Laboratory monitoring
- Imaging follow-up
Quality of Life Assessment:
- Functional status
- School performance
- Psychosocial adaptation
Long-term Surveillance:
- Growth monitoring
- Development tracking
- Complication screening

Clinical Practice Guidelines

IDSA Guidelines for Fever and Neutropenia
ACR Guidelines for JIA Management
International FUO Working Group Recommendations

Key Reference Texts

Nelson Textbook of Pediatrics - Chapter on FUO
Feigin and Cherry's Textbook of Pediatric Infectious Diseases
Pediatric Rheumatology: Clinical Practice

Recent Research Articles

Updates in diagnosis and management of FUO in children (2023)
Biomarker studies in pediatric FUO (2022)
Systematic review of diagnostic strategies (2021)

Disclaimer

The notes provided on Pediatime are generated from online resources and AI sources and have been carefully checked for accuracy. However, these notes are not intended to replace standard textbooks. They are designed to serve as a quick review and revision tool for medical students and professionals, and to aid in theory exam preparation. For comprehensive learning, please refer to recommended textbooks and guidelines.

YouTube

YouTube: Subscribe to Pediatime!